Home
Browse
Search
Statistics
About
Usage
PMID: 22194755
Cole KH, Sosnay PR, Yarmus LB, Zuckerman JB
The Novel CFTR Mutation A457P in a Male with a Delayed Diagnosis of Cystic Fibrosis.
Case Report Med. 2011;2011:903910. Epub 2011 Dec 13.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
0
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:0:156
status:
NEW
view ABCC7 p.Ala457Pro details
Hindawi Publishing Corporation Case Reports in Medicine Volume 2011, Article ID 903910, 4 pages doi:10.1155/2011/903910 Case Report The Novel CFTR Mutation
A457P
in a Male with a Delayed Diagnosis of Cystic Fibrosis Kate H. Cole,1 Patrick R. Sosnay,1 Lonny B. Yarmus,1 and Jonathan B. Zuckerman2 1 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, 1830 East Monument Street, 5th Floor, Baltimore, MD 21208, USA 2 Division of Pulmonary and Critical Care Medicine, Maine Medical Center, 22 Bramhall Street, Portland, ME 04102, USA Correspondence should be addressed to Jonathan B. Zuckerman, zuckej@mmc.org Received 16 August 2011; Revised 21 September 2011; Accepted 25 September 2011 Academic Editor: Mamede de Carvalho Copyright (c) 2011 Kate H. Cole et al.
Login to comment
5
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:5:84
status:
NEW
view ABCC7 p.Ala457Pro details
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:5:93
status:
NEW
view ABCC7 p.Ala457Pro details
We subsequently performed testing, which revealed a previously unreported mutation:
A457P
(p.
Ala457Pro
, c.1369G>C).
Login to comment
7
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:7:4
status:
NEW
view ABCC7 p.Ala457Pro details
The
A457P
mutation appears to confer a relatively mild phenotype, as is usually observed with CFTR class IV-VI defects.
Login to comment
14
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:14:132
status:
NEW
view ABCC7 p.Ala457Pro details
After transfer of care to our institution, a full-sequence CFTR genetic analysis was performed by Ambry Genetics, which revealed an
A457P
mutation in combination with the F508 deletion.
Login to comment
15
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:15:66
status:
NEW
view ABCC7 p.Ala457Pro details
We briefly describe the clinical profile of this patient with the
A457P
mutation, discuss the established criteria used to diagnose CF, and speculate about the possibility that this newly identified variant is a disease-causing mutation.
Login to comment
49
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:49:20
status:
NEW
view ABCC7 p.Ala457Pro details
Testing revealed an
A457P
mutation in exon 10 in combination with the F508 deletion.
Login to comment
51
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:51:119
status:
NEW
view ABCC7 p.Ala457Pro details
A literature review and examination of the Sick Kids Cystic Fibrosis Mutation database revealed no prior report of the
A457P
mutation [10].
Login to comment
69
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:69:58
status:
NEW
view ABCC7 p.Ala457Pro details
Analysis of the previously unidentified genetic variation
A457P
must be considered in the context of its discovery in an individual with an established diagnosis of CF.
Login to comment
75
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:75:117
status:
NEW
view ABCC7 p.Ala457Pro details
Given that CF is an autosomal recessive disease and that our patient is an affected individual, it would appear that
A457P
is a CF-causing mutation in this instance.
Login to comment
78
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:78:86
status:
NEW
view ABCC7 p.Ala457Pro details
Therefore, it is possible, although unlikely, that another mutation is present on the
A457P
chromosome, for example, in an intronic region that may not have been sequenced.
Login to comment
79
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:79:106
status:
NEW
view ABCC7 p.Ala457Pro details
When entered into publicly available in silico mutation prediction tools PolyPhen [13] and SIFT [14], the
A457P
mutation, which resides within the nucleotide binding domain 1 of the CFTR, was predicted to be deleterious; however, these methods have not shown adequate sensitivity or specificity in CF to have clinical utility [15].
Login to comment
80
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:80:41
status:
NEW
view ABCC7 p.Ala457Pro details
Taken together, these findings argue for
A457P
being a disease-causing mutation, though it is still most accurate to formally categorize it as a VUS.
Login to comment
90
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:90:145
status:
NEW
view ABCC7 p.Ala457Pro details
Our patient`s presentation of mild respiratory symptoms and pancreatic sufficiency in association with one known Class II mutation suggests that
A457P
is likely a Class IV-VI mutation (i.e., one that retains some chloride channel function).
Login to comment
91
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:91:73
status:
NEW
view ABCC7 p.Ala457Pro details
Functional testing could help elucidate the cellular consequences of the
A457P
substitution to support the hypothesis that the mutation is deleterious and to assign the mutation to a functional class; however, the considerable resources necessary to perform such confirmatory work would generally make this impractical for a mutation found in a single patient.
Login to comment
94
ABCC7 p.Ala457Pro
X
ABCC7 p.Ala457Pro 22194755:94:71
status:
NEW
view ABCC7 p.Ala457Pro details
Detailed genetic analysis revealed that he carries the novel mutation (
A457P
) along with the most common CFTR mutation (F508del).
Login to comment